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Abstract
Pattern recognition receptors are a key component of the first line host defense against infection,
recognizing specific microbial products. We hypothesize that monocyte hyporesponsiveness in
human sepsis is associated with a downregulation of the pattern recognition receptors Toll-like
receptor (TLR)-2 and TLR4.
Protein expression of CD14, TLR2 and TLR4 on blood monocytes was examined using flow
cytometry from 29 patients with sepsis and 14 healthy controls. In addition LPS stimulated TNF-α
and IL-10 production was studied in a 24 hour whole blood assay.
We found an increased expression of CD14, TLR2 and TLR4 in patients with sepsis compared to
controls (p < 0.01). In patients with sepsis, death was associated with significant lower CD14 and
TLR2 expression at admission (CD14: 25.7 +- 19.1 vs 39.1 +- 17.3 mean fluorescence intensity
[MFI], p = 0.02; TLR2: 21.8 +- 9.4 vs. 30.9 +- 9.6, p = 0.01). At 72 hours the TLR2 expression on
monocytes was associated with the IL-10 inducibility after LPS stimulation (r = 0.52, p = 0.02) and
the CD14 expression with the IL-6, IL-10 and TNF inducibility.
We conclude that septic patients are characterized by an increased expression of CD14, TLR2 and
TLR4 on monocytes compared to controls. Death is associated with downregulation of TLR2 and
CD14 expression on monocytes correlating with reduced cytokine inducibility. We suggest that
CD14 and TLR2 are a key factor in monocyte hyporesponsibility during severe sepsis.
Background
Severe sepsis is the cause of 9% to 22% intensive care unit
admissions and is associated with a mortality rate up to
50% [1]. Bacterial antigens trigger the initial cytokine
response to infection, which is necessary for the clearance
of invading pathogens, but overwhelming activation of
immune cells, with excessive production of pro-inflam-
matory cytokines such as tumor necrosis factor (TNF)-α
and interleukin (IL)-6, is thought to be responsible for the
clinical manifestation of septic shock [2,3].
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Recognition of pathogen associated molecular pattern
(PAMP) by the innate immune system is mediated by pat-
tern recognition receptors (PRR) on leucocytes and epi-
thelial cells.
TLR4, together with CD14 and the MD2 adapter mole-
cule, serves as the main receptor for components from
gram negative bacteria such as lipopolysaccharide (LPS)
[4], whereas TLR2 is crucial to the propagation of the
inflammatory response to components mainly from
gram-positive organisms, yeast and mycobacteria includ-
ing lipoteichonic acid (LTA) and lipoarabinomannan [5-
7]. In addition, TLR2 is activated by bacterial peptidogly-
can, bacterial lipoproteins and lipopeptides, cell wall
structures expressed on virtually all clinically relevant
gram positive and gram negative bacterial pathogens [8].
TLR2 might also be involved in LPS induced cell activa-
tion since anti-TLR2 antibody partially inhibits IL-12 pro-
duction of human dendritic cells [9]. TLR activation
causes nulear factor kB translocation and mitogen-acti-
vated protein kinase phosphorylation, resulting in an
enhanced production of inflammatory cytokines such as
TNF, IL-1 and IL-6 [4]. In murine macrophages TLR4
expression correlates with the inducibility of the proin-
flammatory response to LPS [10], whereas stimulation
with TLR2 agonist has been associated with the rapid
release of IL-10 [11].
The central role of TLR2 and TLR4 in microbial responses
suggests that they may be implicated in the pathophysiol-
ogy and the outcome of human sepsis [12]. Beside initial
systemic release of proinflammatory cytokines, prolonged
cellular hyporesponsiveness to bacterial components with
reduced cytokine response is thought to be a key factor in
sepsis with limitation of subsequent ability to mount an
appropriate inflammatory defense to secondary infec-
tions. TLR regulation might be implicated in hyporespon-
siveness, since prolonged LPS-stimulation of human
macrophages caused downregulation of TLR2 [13]. In
addition tolerance in vitro to bacterial lipoprotein, a com-
pound of gram-positive and gram-negative bacteria, is
associated with reduced TLR2 expression [14].
In contrast to data describing TLR downregulation after
LPS in vitro, murine sepsis is associated with an increased
TLR4 protein expression in tissue [15]. In human sepsis
increased protein expression and mRNA of TLR2 and
TLR4 on blood neutrophils and monocytes are found
compared to healthy individuals [16,17]. Thus, experi-
mental models in animals and septic human patients dis-
play significantly upregulated TLR expression. But, in
contrast to the resting state and nonseptic situation
peripheral blood monocytes from septic patients secrete
reduced quantities of proinflammatory cytokines regard-
less of their up regulated TLR-expression [18-21], possibly
due to intracellulary inhibitory processes [22].
In addition to the questionable functional activity of TLR
receptors during sepsis, expression of TLR during human
sepsis was not associated with clinical outcome.
We hypothesized that TLR and CD14 expression is
increased in sepsis, but inadequately less increased in
severe sepsis compared to nonsevere sepsis, possibly asso-
ciated to monocyte hyporesponsiveness.
We therefore compared the TLR2, TLR 4 and CD14 expres-
sion on blood monocytes of patients with sepsis and
healthy controls. In patients with sepsis the TLR expres-
sion on monocytes was measured sequentially (admis-
sion, day 1, day 3, day 7) and correlated with sepsis
severity and mortality. To evaluate the functional rele-
vance of the receptor expression, we correlated the TLR
and CD14 expression with the cytokine release after stim-
ulation with LPS in a whole blood assay.
Methods
Sepsis patients
Twentynine patients with sepsis (defined according to 23)
were investigated in a prospective manner. Patients below
18 years or with defined immunodeficiencies (hemato-
logic or solid neoplasia, glucocorticoid or cytotoxic ther-
apy, HIV infection or immunoglobulin deficiency) were
excluded from the study.
The source of sepsis was the lung (n = 14), urinary tract (n
= 8), meningitis (n = 2), gastrointestinal (n = 3), endocar-
ditis (n = 1) and skin (n = 1). 28 von 29 (96,55%) patients
had a predisposing chronic disease (pulmonary disease,
cardiovascular disease, neurologic disease, renal insuffi-
ciency, diabetes mellitus).
Healthy controls
14 unrelated healthy persons, all of white origin without
signs of inflammatory disease served as a control group.
The study was approved by the institutional ethics com-
mittee. Written informed consent was obtained from
patients or their relatives and healthy volunteers.
Study protocoll
Venous blood samples were obtained once in healthy
controls and at admission (t0), 24 hours (t1), 72 hours
(t2) and 7 days (t3).
Sepsis severity
The disease severity was definded by the acute physiology
score (APS), the APACHE II Score (including APS) and
clinical/laboratory parameters. Septic shock was defined
as sepsis associated with sepsis induced systolic bloodDiagnostic Pathology 2009, 4:12 http://www.diagnosticpathology.org/content/4/1/12
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pressure of < 90 mmHg for at least 30 min in the absence
of other causes of shock, and at least 4 h of inotropic sup-
port after adequate fluid replacement were required [23].
PBMC purification and flow cytometry
30 ml of blood was obtained by venepuncture and col-
lected into sterile heparinized tubes, PBMC were isolated
by Bicoll/Ficoll density gradient centrifugation. PBMCs
were cultured in 24-well tissue plates (Biochrome, Berlin,
Germany) using endotoxin-free RPMI 1640 medium
(Biowhittaker, Belgium) supplemented with 2 mM L-
glutamine (Gibco, Eggenstein, Germany) at a density of
0.5 × 106 cells/ml at 37°C in a 5% CO2 humidified atmos-
phere for a period of 3 h. The expression of TLR2, TLR4
and CD14 on monocytes was determined using a fluores-
cence activated cell sorter (FACS Calibur, Becton Dickin-
son, Heidelberg, Germany). Data acquisition and analysis
were performed with CellQuest software (Becton Dickin-
son, Heidelberg, Germany). Each measurement contained
≥ 10,000 cells in the monocyte population determined by
characteristic forward/orthogonal light scattering in a
density plot. Antibodies against the following epitopes
were used. PE-labeled: TLR2, TLR4, CD14 isotype controls
(eBioscience, San Diego, USA). PBMC (1 × 106) were
incubated on 4°C with 5 μl of anti-TLR2, -TLR4 PE mon-
oclonal antibody respectively or isotype control. The
expression of surface markers was calculated as mean flu-
orescence intensity (MFI) since no bimodal distribution
was found.
Whole blood stimulation and cytokine assays
Whole blood stimulation assay was done as described pre-
viously [24]. In brief, 2,5 mL of heparinized blood was
diluted 1:10 with RPMI 1640 (Biochrome, Berlin, Ger-
many) supplemented with Pen/Strep 1% (Gibco, Ger-
many) and immediately stimulated with 1 μg/mL LPS
from Escherichia coli serotype 026:B6 (Sigma, St. Louis,
USA) or with 100 μg/ml LTA from Stapylococcus aureus
(Sigma L2515, St. Louis, USA) Samples were incubated in
PPN tubes at 37°C with 5% CO2. Each experiment also
included controls without LPS or LTA. Cell-free superna-
tants were removed after 24 h and stored at -80°C until
assayed. Measurement of supernatant IL-6, TNF and IL-10
levels was performed using commercially available
enzyme-linked immunosorbent assay kits, according to
manufacturer's instructions (Biosource, Solingen, Ger-
many).
Statistics
Nonparametric statistics were used throughout the study.
Data are given as mean ± SD. The Wilcoxon signed rank
test was used for comparison of paired samples, for com-
parisons of independent samples the Mann-Whitney-U-
test was used. Correlations were made with the Spear-
man's rank correlation. Calculations were carried out with
Statistica for Windows, version 5, 1997. A p value of <
0.05 was considered significant.
Results
Patients
Demographic data of the study population are shown in
table 1.
TLR expression of sepsis patients compared to healthy 
controls
The monocyte expression of TLR2, TLR4 and CD14 was at
all timepoints [admission (t0), day 1 (t1) day 3 (t2) and
day 7 (t3)] significantly higher in patients with sepsis
compared to the monocyte expression in healthy controls
(figure 1a). In healthy controls and in patients (at all time
points) the TLR2, TLR4 and CD14 expression correlated
significantly (figure 1b, p < 0.001 for all timepoints).
TLR expression during the course of sepsis
TLR-2 expression was downregulated between t0 and t3
(28.2 +- 10.3 vs. 23.8 +- 6.7 MFI; p = 0.01). CD14 was
downregulated between t0 and t3 without reaching signif-
icance (35.1 +- 18.6 vs 31.6 +- 13.2; p = 0.07). TLR-4 was
not regulated between t0 and t3 (6.6 +- 1.9 vs 6.5 +- 1.8;
p = 0.35; figure 2).
TLR expression according to sepsis severity
Death was associated with lower TLR-2, TLR-4 and CD-14
expression on blood monocytes, reaching significant val-
ues for TLR2 (at t0, t1 and t2) and CD-14 (at t0, table 2).
Patients with septic shock had a lower TLR-2 and CD-14
expression than patients without shock at t0, t1 and t2
without reaching significance (data not shown)
No correlation was found between TLR-2, TLR-4 or CD-14
expression and APS, APACHE II or Serum-CRP values
(data not shown).
Table 1: Demographic and clinical data of 29 patients with 
sepsis.
age (Mean ± std.dev.) in years 68,55 ± 11,8
Male 14 (0,48)
APS 21,55 ± 7,50
APACHE II 30,86 ± 9,72
28 day mortality 8 (27,6%)
sepsis severity
Sepsis 5 (17,2%)
severe Sepsis 5 (17,2%)
sept. Schock 12 (41,4%)
MODS 7 (24,1%)
septic complications
acute renal failure 12 (41,4%)
DIC 7 (24,1%)
respiratory failure 19 (65,5%)Diagnostic Pathology 2009, 4:12 http://www.diagnosticpathology.org/content/4/1/12
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Cytokine inducibility in whole blood stimulation assay
To test the cytokine inducibility and the hyporesponsive-
ness during sepsis, a whole blood assay with LPS in vitro
stimulation was used.
Hyporesponsiveness was seen with lower IL-6, TNF and
IL-10 inducibility at t0 compared with t3 without reach-
ing significance (IL-6 t0: 3226 +- 4584 vs t3: 6563 +- 4923
pg/ml; p = 0.08, TNF t0: 664 +- 876 vs t3: 1278 +- 1234
pg/ml; p = 0.1, IL-10 t0: 20 +- 23 vs t3: 32 +- 22 pg/ml; p
= 0.17).
To test the functional activity of TLR-2, TLR-4 and CD14,
the cytokine inducibility after LPS stimulation was corre-
lated with the receptor expression:
At t2, the TLR-2 expression was associated with the IL-10
inducibility (r = 0.52; p = 0.02, figure 3a) and the CD-14
expression was associated with the IL-6 (r = 0.49; p =
A: Flow cytometry expression of TLR2, TLR4 and CD14 on monocytes Figure 1
A: Flow cytometry expression of TLR2, TLR4 and CD14 on monocytes. MFI ± SD is shown from healthy volunteers 
(H) and patients with sepsis (P). * = p < 0.01 vs. controls. MFI = mean fluorescence intensity. B: Correlation between TLR2 
and TLR4 in patients with sepsis (r = 0.69, p < 0.001).
Flow cytometry expression of TLR2, TLR4 and CD14 on monocytes during course of sepsis Figure 2
Flow cytometry expression of TLR2, TLR4 and CD14 on monocytes during course of sepsis. MFI ± SD is shown. * 
= p < 0.01 vs. t0. MFI = mean fluorescence intensity.Diagnostic Pathology 2009, 4:12 http://www.diagnosticpathology.org/content/4/1/12
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0.04), the IL-10 (r = 0.49; p = 0.04, figure 3b) and the TNF
inducibility (r = 0.62; p = 0.03).
Discussion
As shown by other investigators before, CD14, TLR2 and
TLR4 protein expression on monocytes is elevated during
sepsis. Interestingly we could show in our study a rela-
tively lower receptor expression (CD14, TLR2 and as a
trend in TLR4), in patients with sepsis that died, com-
pared to patients that survived (Table 2). In addition we
were able to demonstrate a correlation between receptor
expression and cytokine production after LPS stimulation,
leading to the assumption that the receptors on mono-
cytes are functionally active during sepsis. These data
underline the pathophysiologic role of TLR2 and CD14
for the activation of the immune system and the mono-
cyte hyporesponsiveness in severe human sepsis.
As microorganisms trigger the release of cytokines via
TLR's and CD14, these receptors are thought to play a cen-
tral role in the pathophysiology of sepsis. The ability of
the host to sense invasion of pathogenic organism and
respond appropriately to control infection is critical to
survival. Sepsis can induce monocyte hyporesponsive-
ness, limiting the antigen induced cytokine release caus-
ing immunosuppression. In vitro LPS stimulation is able
to cause a downregulation of TLR2 and TLR4 gene expres-
sion and surface expression on mouse macrophages
inducing monocyte hyporesponsiveness [25-27]. In con-
trast to downregulation of TLR gene expression after LPS
exposure in cell culture, sepsis in mice [15] and humans
sepsis causes an upregulation of TLR2, TLR4 and CD14
expression on blood monocytes (table 1). Similar data
have been shown by other authors before [28,29]. Contin-
uous microbial stimulation during bacterial sepsis with a
number of different antigenic structures might result in
cell activation inducing receptor upregulation [11]. Caus-
ative factors might be the release of cytokines during sep-
sis like IL-6, which has been shown to upregulate TLR4 on
human monocytes [21]. In addition neutrophil products
like elastase induces TLR4 expression on human mono-
cytes [16].
Table 2: TLR and CD14 protein expression on monocytes of 







T0 30.9 (+- 9.6) 21.8 (+- 9.4) 0.01
T1 30.5 (+- 7.6) 21.8 (+- 10.6) 0.02
T2 23.1 (+- 6.0) 18.7 (+- 4.5)* 0.04
T3 24.7 (+- 6.1) 20.4 (+- 8.6)** 0.3
TLR4
T0 7.0 (+- 1.8) 5.7 (+- 2.0) 0.07
T1 7.4 (+- 1.8) 6.5 (+- 3.3) 0.08
T2 6.1 (+- 2.1) 6.5 (+- 1.3)* 0.9
T3 6.6 (+- 1.9) 6.1 (+- 1.8)** 0.6
CD14
T0 39.1 (+- 17.3) 25.7 (+- 19.1) 0.02
T1 40.7 (+- 19.1) 24.7 (+- 18.0) 0.06
T2 34.2 (+- 20.2) 26.5 (+- 10.1)* 0.2
T3 31.3 (+- 12.5) 32.7 (+- 16.9)** 0.9
T0 = admission, T1 = 24 hours, T2 = 72 hours, T3 = 7 days. (Values 
as MFI), * n = 6, ** n = 5, less patients due to death
Correlation between TLR2 (A, r = 0.52; p = 0.02, figure 3a), CD14 (B, r = 0.49; p = 0.04, figure 3b) and IL-10 secretion of  whole blood in response to LPS-stimulation at t2 in patients with sepsis Figure 3
Correlation between TLR2 (A, r = 0.52; p = 0.02, figure 3a), CD14 (B, r = 0.49; p = 0.04, figure 3b) and IL-10 
secretion of whole blood in response to LPS-stimulation at t2 in patients with sepsis.Diagnostic Pathology 2009, 4:12 http://www.diagnosticpathology.org/content/4/1/12
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In our study patients that died had lower cytokine induc-
ibility at all timepoints and therefore more intensive
hyporesponsiveness than patients that survived (n.s.).
Correlating with this result, lower CD14 and TLR2 expres-
sion was found in patients that died (Table 2). In addi-
tion, at day 3 cytokine in vitro inducibility (24 hours
whole blood LPS-stimulation) correlated with the TLR2
and CD14 protein expression on blood monocytes. Our
data indicate that during the course of sepsis the receptors
gain again functional activity, with higher cytokine release
after in vitro antigen stimulation in cells with higher
receptor expression. The data with lower receptor expres-
sion in patients that died during sepsis, confirm recent
data, showing reduced gene expression for TLR receptors
in monocytes of patients according to their state of sepsis:
lowest TLR gene expression in septic shock, followed by
severe sepsis and sepsis [30,31]. In addition to Salomao's
gene results, we were able to associate TLR protein expres-
sion to sepsis severity. In conclusion, inadequate receptor
activation might be deleterious for patients with sepsis.
A few years ago, TLR2 was thought to be a specific receptor
for antigens from gram positive and the TLR2/CD14 com-
plex was thought to be specific for gram negative antigenic
structures. Several recent studies have shown that these
receptors are not as specific as thought. Lipoteichonic acid
(LTA) from S. pneumonia is able to activate TLR2 and
CD14 [32]. In contrast LPS from gram negative bacteria is
able to activate also CD14 and TLR2. The contribution of
these receptors for host response during infection has
been studied in animal knock out models. For example,
TLR2 knock out causes reduced inflammatory response to
pneumococcal LTA [32]. A strong pro-inflammatory reac-
tion is necessary for local bacterial clearance. As shown in
our study, an inadequate downregulation of TLR2 and
CD14 (and consecutive reduced cytokine release) during
sepsis might have a negative influence on outcome. In
addition to reduced bacterial clearance, monocyte
hyporesponsiveness has been associated with increased
number of nosocomial infections in septic patients.
Beside innate immune response, the TLR2 induced
cytokine response might also be involved in the physio-
logic endocrine response to sepsis, since TLR2 deficient
mice have an impaired cytokine mediated corticosteroid
adrenal stress response [33]. Taken together, these data
suggest that a reduced TLR2 and CD14 expression during
sepsis might have a negative outcome in sepsis.
Therapies targeting TLR-pathways are currently being
investigated for several diseases. Whether TLR blocking
[34] or TLR agonists [35] are needed in sepsis is under dis-
cussion. Broad knowledge about the regulation of TLR
and CD14 induced signalling pathways are needed to
anticipate the clinical effect. Our data suggest that addi-
tional TLR blocking in patient with sepsis might be dan-
gerous.
Conclusion
In conclusion septic patients are characterized by an
increased TLR2, TLR4 and CD14 expression. Death due to
sepsis is associated with TLR2 and CD14 downregulation.
The precise role of TLR and CD14 regulation in sepsis
should be evaluated in further clinical and experimental
studies, especially before TLR blocking agents are clini-
cally investigated.
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